comparemela.com

Latest Breaking News On - Timely antithrombotic removal ticagrelor - Page 13 : comparemela.com

CytoSorbents to Report First Quarter 2022 Operating and Financial Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesEric kimUs department of healthHuman servicesMaterial commandNational institutes of healthUs airCorporate communicationsEuropean unionUs armyBlood instituteCytosorbents corporationNational heartSorbents corporationInvestor relationsUse authorization

CytoSorbents To Expand Direct Sales of CytoSorb® to the United Kingdom, the Sixth Largest Medical Device Market in the World

MONMOUTH JUNCTION, N.J., April 14, 2022 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening con.

United statesUnited kingdomRepublic of irelandChristian steinerEric kimMaterial commandEuropean unionUs armyBlood instituteCytosorbents corporationNational heartUnited kingdom national health serviceNational institutes of healthHuman servicesUs department of healthUs air

CytoSorbents Receives Approximately $740,000 from the New Jersey Business Tax Certificate Transfer Program

MONMOUTH JUNCTION, N.J., April 7, 2022 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening cond.

United statesNew jerseyMonmouth junctionState of new jerseyEric kimKathleen blochMaterial commandDevelopment tax credits rdTechnology business tax certificate transfer programJersey division of taxationJersey economic development authorityEuropean unionUs armyBlood instituteNational heartCytosorbents corporation

CytoSorbents Highlights Activities at the Live 41st International Symposium on Intensive Care and Emergency Medicine (ISICEM)

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

Nordrhein westfalenUnited statesGabriella bottari bambinoEric kimPhillip chanYatin mehtaMalbrain leuvenAxel nierhaus university medical center hamburgMaterial commandEuropean unionUs armyCytosorbents corporationNational heartBlood instituteInstitute of critical careNational institutes of health

CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesEric kimUs department of healthHuman servicesMaterial commandNational institutes of healthUs airCorporate communicationsEuropean unionUs armyBlood instituteCytosorbents corporationNational heartSorbents corporationInvestor relationsUse authorization

vimarsana © 2020. All Rights Reserved.